TNFSF10 and ovarian cancer: The same mechanism was also reported in relation to ovarian cancer, where activation of AMPK increased the sensitivity of TNF-related apoptosis-inducing ligand (TRAIL), thereby reducing the protein expression of MCL-1, a group of antiapoptotic proteins [179].